From: Cutaneous nociception and neurogenic inflammation evoked by PACAP38 and VIP
 | VIP | PACAP38 | Placebo |
---|---|---|---|
VASAUC (cm × s) | 1.2 (0.6–1.7)* | 1.0 (0.4–1.6)* | 0.2 (0–0.4) |
Pain distribution area (cm2) | 5.3 ± 8.0* | 2.9 ± 5.3* | 1.6 ± 3.5 |
Peak pain (VAS) | 1.3 (0.9–2.8) | 1.7 (1.0–2.2) | 0.5 (0–1.2) |
Pain time (s) | 96 (83–136) | 63 (49–120) | 26 (2–59) |